President Trump’s tariffs are impacting the medical device industry in significant ways, with individual companies facing hundreds of millions of dollars in added costs. While some of the largest manufacturers are finding ways to mitigate these tariffs, smaller firms are feeling the financial strain.
Boston Scientific, a prominent medical device manufacturer, is expecting to offset $200 million in tariffs this year through a combination of increased sales and cost-cutting measures. Similarly, Intuitive Surgical, known for its da Vinci surgical robot system, saw its stock price rise after announcing that its products manufactured in Mexico would not be subject to tariffs. Despite facing a total tariff hit of $165 million this year, representing about 1.7% of its annual revenue, Intuitive Surgical is in a better position than initially anticipated.
On the other hand, some companies, like Resmed, have managed to avoid the negative impact of tariffs altogether. Resmed recently announced that its sleep apnea machines will remain tariff-free due to a little-known exemption from the U.S. Customs and Border Protection. This exemption has allowed Resmed to continue operating without the added financial burden imposed by tariffs.
The tariffs imposed by President Trump are reshaping the landscape of the medical device industry, with larger manufacturers finding ways to navigate the challenges while smaller companies are feeling the strain. As the industry continues to adapt to these new economic realities, it is essential for companies to remain agile and innovative in order to thrive in a rapidly changing market.
